| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q33376143 | A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer |
| Q38690495 | Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis. |
| Q38394502 | Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC). |
| Q47737687 | Clinical development of mTor inhibitors for renal cancer |
| Q36313559 | Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review. |
| Q38648461 | Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials |
| Q33389403 | Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen. |
| Q33411751 | Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial |
| Q38764838 | FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer: A Systematic Review and Pooled Analysis |
| Q36636651 | Immunotherapy options in metastatic renal cell cancer: where we are and where we are going. |
| Q33436065 | Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity |
| Q39204464 | Overview of different available chemotherapy regimens combined with radiotherapy for the neoadjuvant and definitive treatment of esophageal cancer |
| Q33374065 | Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report |
| Q26825116 | Pituitary gland metastasis from rectal cancer: report of a case and literature review |
| Q36309934 | Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies |
| Q36175906 | Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis |
| Q38241985 | Ramucirumab for metastatic gastric or gastroesophageal junction cancer: results and implications of the REGARD trial. |
| Q33435455 | Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer |
| Q33388484 | Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II tr |
| Q38731943 | Targeted therapies in gastric cancer treatment: where we are and where we are going. |
Search more.